Shuling Guo

4.0k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

Shuling Guo is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Shuling Guo has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 13 papers in Genetics and 13 papers in Cancer Research. Recurrent topics in Shuling Guo's work include Cancer-related molecular mechanisms research (12 papers), RNA Research and Splicing (11 papers) and RNA modifications and cancer (8 papers). Shuling Guo is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA Research and Splicing (11 papers) and RNA modifications and cancer (8 papers). Shuling Guo collaborates with scholars based in United States, China and United Kingdom. Shuling Guo's co-authors include Brett P. Monia, Sheri Booten, Maite Huarte, Jovanna González, Alejandro Athie, Oskar Marín-Béjar, Mariam Aghajan, Audrey Low, Lulu Huang and Francesco P. Marchese and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Shuling Guo

49 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice

2014 468 citations Thazha P. Prakash, Audrey Low et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuling Guo United States	25	2.1k	958	239	180	175	53	2.6k
Zhijian Qian United States	27	1.9k 0.9×	750 0.8×	136 0.6×	60 0.3×	206 1.2×	58	2.6k
Irene K. Yan United States	30	3.2k 1.5×	2.5k 2.6×	237 1.0×	91 0.5×	222 1.3×	63	4.0k
A. Robert MacLeod United States	29	2.9k 1.4×	2.0k 2.0×	583 2.4×	282 1.6×	81 0.5×	57	4.0k
Eugenio Gaudio Switzerland	23	2.2k 1.1×	1.1k 1.1×	152 0.6×	109 0.6×	81 0.5×	92	2.8k
Roland Kappler Germany	29	1.6k 0.8×	399 0.4×	100 0.4×	142 0.8×	110 0.6×	96	2.4k
Florence Schaffner United States	22	1.1k 0.5×	305 0.3×	268 1.1×	349 1.9×	231 1.3×	26	2.1k
Juxiang Chen China	29	1.5k 0.7×	864 0.9×	457 1.9×	57 0.3×	188 1.1×	76	2.6k
Andrew T. Jacovina United States	15	1.5k 0.7×	716 0.7×	69 0.3×	84 0.5×	113 0.6×	16	2.3k
Ignacio Varela Spain	23	2.4k 1.2×	569 0.6×	343 1.4×	35 0.2×	172 1.0×	54	3.3k
Jamie N. Anastas United States	9	2.0k 1.0×	426 0.4×	181 0.8×	76 0.4×	258 1.5×	10	2.5k

Countries citing papers authored by Shuling Guo

Since Specialization

Citations

This map shows the geographic impact of Shuling Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Guo more than expected).

Fields of papers citing papers by Shuling Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuling Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Guo. The network helps show where Shuling Guo may publish in the future.

Co-authorship network of co-authors of Shuling Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Shuling Guo. A scholar is included among the top collaborators of Shuling Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuling Guo. Shuling Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Antipova, Olga, Barry Lai, Martina Ralle, et al.. (2025). Studies of Slc30a10 Deficiency in Mice Reveal That Intestinal Iron Transporters Dmt1 and Ferroportin Transport Manganese. Cellular and Molecular Gastroenterology and Hepatology. 19(7). 101489–101489.

Guo, Shuling, et al.. (2024). Hepatic HIF2 is a key determinant of manganese excess and polycythemia in SLC30A10 deficiency. JCI Insight. 9(10). 3 indexed citations

Guo, Shuling, et al.. (2024). (S _C,R _S)-Bromido(N-{4-methyl-1-[(4-methylphenyl)sulfanyl]pentan-2-yl}-N′-(pyridin-2-yl)imidazol-2-ylidene)palladium(II) bromide. SHILAP Revista de lepidopterología. 9(4). x240360–x240360.

Sutharsan, Sivagurunathan, Rainald Fischer, Wolfgang Gleiber, et al.. (2024). Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC. ERJ Open Research. 10(4). 986–2023. 1 indexed citations

Guo, Shuling, et al.. (2024). Combination of a TGF‐β ligand trap (RAP‐GRL) and TMPRSS6‐ASO is superior for correcting β‐thalassemia. American Journal of Hematology. 99(7). 1300–1312. 5 indexed citations

Wang, Yali, Jiangang Wang, Shuling Guo, et al.. (2023). Oligomeric β-Amyloid Suppresses Hippocampal γ-Oscillations through Activation of the mTOR/S6K1 Pathway. Aging and Disease. 14(4). 0–0. 2 indexed citations

Guo, Shuling, et al.. (2023). Review of different temperatures for biopreservation. International Journal of Refrigeration. 157. 53–59. 6 indexed citations

Yong, Jing, Vishal S. Parekh, Shannon M. Reilly, et al.. (2021). Chop / Ddit3 depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice. Science Translational Medicine. 13(604). 49 indexed citations

Garcia, Daniel, Andrew F. Powers, Thomas A. Bell, Shuling Guo, & Mariam Aghajan. (2021). Antisense Oligonucleotide-Mediated Silencing of Mitochondrial Fusion and Fission Factors Modulates Mitochondrial Dynamics and Rescues Mitochondrial Dysfunction. Nucleic Acid Therapeutics. 32(1). 51–65. 6 indexed citations

10.

Boyd, A. Christopher, Shuling Guo, Lulu Huang, et al.. (2020). New approaches to genetic therapies for cystic fibrosis. Journal of Cystic Fibrosis. 19. S54–S59. 48 indexed citations

11.

Viney, Nicholas J., Shuling Guo, Bruce L. Tai, et al.. (2020). Ligand Conjugated Antisense Oligonucleotide for the Treatment of Transthyretin Amyloidosis: Preclinical and Phase 1 Data. ESC Heart Failure. 8(1). 652–661. 65 indexed citations

12.

Aghajan, Mariam, Sheri Booten, Magnus Althage, et al.. (2019). Antisense oligonucleotide treatment ameliorates IFN-γ–induced proteinuria in APOL1-transgenic mice. JCI Insight. 4(12). 69 indexed citations

13.

Keenan, Melissa M., Lulu Huang, Eric C. Wong, et al.. (2019). Nonsense-mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTR. American Journal of Respiratory Cell and Molecular Biology. 61(3). 290–300. 46 indexed citations

14.

Huang, Lulu, Mariam Aghajan, Audrey Low, et al.. (2019). Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations. Nucleic Acid Therapeutics. 29(4). 175–186. 20 indexed citations

15.

Duong, Connie P.M., Michael Fazio, Cathy Chen, et al.. (2019). MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma. Nanomedicine Nanotechnology Biology and Medicine. 24. 102127–102127. 22 indexed citations

16.

Shukla, Sudhanshu, Xiang Zhang, Yashar S. Niknafs, et al.. (2016). Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer. Neoplasia. 18(8). 489–499. 56 indexed citations

17.

Schmitt, Adam M., Julia T. Garcia, Tiffany Hung, et al.. (2016). An inducible long noncoding RNA amplifies DNA damage signaling. Nature Genetics. 48(11). 1370–1376. 183 indexed citations

18.

Huang, Lulu, Sagar Damle, Sheri Booten, et al.. (2015). Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration. PLoS ONE. 10(7). e0132798–e0132798. 26 indexed citations

19.

Lieberman, Andrew P., Zhigang Yu, Sue Murray, et al.. (2014). Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy. Cell Reports. 7(3). 774–784. 128 indexed citations

20.

Guo, Shuling, Sheri Booten, Mariam Aghajan, et al.. (2013). Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin–related liver disease in mice. Journal of Clinical Investigation. 124(1). 251–261. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact